APA (7th ed.) Citation

S, S., H, P., K, E., R, R., AA, B., S, D., . . . CD, B. (2025). BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension. Respiratory medicine, 248, 108318. https://doi.org/10.1016/j.rmed.2025.108318

Chicago Style (17th ed.) Citation

S, Sahay, et al. "BREEZE Optional Extension Phase: Long-term Safety and Efficacy of Treprostinil Dry Powder Inhaler (Tyvaso DPI) in Pulmonary Arterial Hypertension." Respiratory Medicine 248 (2025): 108318. https://doi.org/10.1016/j.rmed.2025.108318.

MLA (9th ed.) Citation

S, Sahay, et al. "BREEZE Optional Extension Phase: Long-term Safety and Efficacy of Treprostinil Dry Powder Inhaler (Tyvaso DPI) in Pulmonary Arterial Hypertension." Respiratory Medicine, vol. 248, 2025, p. 108318, https://doi.org/10.1016/j.rmed.2025.108318.